立康

0.00 (0.00%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

34.001成交張數14.17本益比1.28股價淨值比5.88%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	11	8	25.9%	1.04	26.50	9.1%	6.8%	0.2	-0.1
2026Q1	11	9	19.4%	1.57	27.71	8.9%	7.1%	-0.0	-0.1
2025Q4	11	9	20.3%	1.50	27.39	9.7%	7.9%	0.7	0.0
2025Q3	12	8	27.1%	1.22	26.52	9.8%	7.6%	-0.1	-1.7
2025Q2	11	8	25.5%	1.80	26.15	10.4%	7.7%	0.1	-0.7
2025Q1	11	9	20.1%	3.84	27.36	9.4%	7.5%	0.2	-0.0
2024Q4	10	9	17.4%	5.45	26.90	10.4%	8.3%	0.5	-0.1
2024Q3	10	8	16.5%	6.85	26.09	11.5%	9.2%	0.1	0.1
2024Q2	11	8	26.7%	3.56	25.50	12.1%	9.2%	0.0	-0.1
2024Q1	11	9	18.6%	5.28	27.33	13.0%	10.7%	0.1	0.1
2023Q4	8	6	23.8%	3.24	23.50	18.5%	14.6%	0.6	0.6
2023Q3	8	6	23.8%	3.19	22.47	20.3%	15.9%	0.0	0.0
2023Q2	7	6	20.3%	2.42	24.91	23.7%	18.1%	0.1	0.1
2023Q1	7	6	16.8%	2.85	25.54	22.9%	18.7%	0.3	0.3
2022Q4	7	6	17.2%	2.61	24.46	21.1%	17.2%	0.7	0.6
2022Q3	7	5	19.3%	2.56	23.12	19.3%	15.5%	0.6	0.6
2022Q2	7	5	27.2%	1.89	22.68	15.1%	11.0%	0.1	0.1
2022Q1	6	5	19.8%	2.56	22.87	10.8%	8.4%	0.2	0.2
2021Q4	6	5	20.1%	2.45	22.16	10.3%	8.2%	0.6	0.6
2021Q3	6	5	19.6%	2.35	21.34	12.9%	10.2%	-0.0	-0.0
2021Q2	6	5	27.4%	1.71	21.12	17.2%	12.6%	-0.1	-0.1
2021Q1	7	5	23.8%	2.23	23.40	14.9%	11.6%	0.1	0.1
2020Q4	6	5	21.2%	2.83	22.90	14.0%	10.9%	0.4	0.4
2020Q3	6	5	22.1%	2.54	21.48	12.9%	10.1%	0.5	0.4
2020Q2	6	5	26.4%	1.89	20.34	10.3%	7.4%	0.1	0.1
2020Q1	6	5	20.6%	2.67	21.97	12.1%	9.5%	-0.1	-0.1
2019Q4	6	5	22.8%	2.37	21.78	15.2%	11.7%	0.5	0.5
2019Q3	6	5	21.1%	2.43	20.76	15.4%	12.0%	0.1	0.1
2019Q2	6	4	29.9%	1.69	20.26	16.2%	11.2%	0.1	0.1
2019Q1	6	5	22.9%	2.38	21.82	15.7%	12.0%	0.3	0.3
2018Q4	6	5	23.4%	2.22	21.03	16.8%	12.7%	0.3	0.3
2018Q3	6	4	23.6%	2.05	20.11	20.0%	15.1%	0.1	-0.6
2018Q2	6	4	31.6%	1.86	19.53	34.9%	22.8%	0.4	0.4
2018Q1	6	5	23.5%	2.99	20.96	33.8%	23.7%	0.2	0.2
2017Q4	6	4	25.2%	2.81	20.08	34.0%	23.2%	0.4	0.4
2017Q3	6	4	26.1%	2.55	18.72	34.7%	23.2%	0.2	0.2
2017Q2	6	4	38.3%	1.41	15.86	22.0%	13.2%	0.3	0.3
2017Q1	6	4	36.9%	1.61	16.01	20.5%	12.2%	0.1	0.1
2016Q4	6	3	38.6%	1.46	15.35	–	–	0.3	0.3
2016Q3	5	3	40.7%	1.42	14.29	–	–	0.2	0.2